Antiepileptic drugs and apoptosis in the developing brain

被引:225
作者
Bittigau, P [1 ]
Sifringer, M [1 ]
Ikonomidou, C [1 ]
机构
[1] Humboldt Univ, Charite Virchow Clin, Childrens Hosp, Dept Pediat Neurol, D-13353 Berlin, Germany
来源
NEUROPROTECTIVE AGENTS | 2003年 / 993卷
关键词
development; apoptosis; neurodegeneration; rat; neurotrophin;
D O I
10.1111/j.1749-6632.2003.tb07517.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epilepsy is the most common neurologic disorder in young humans. Antiepileptic drugs (AEDs), used to treat seizures in children, infants, and pregnant women, cause cognitive impairment, microcephaly, and birth defects by unknown mechanisms. We tested whether common AEDs cause neurodegeneration in the developing rat brain. Rats aged 3-30days received phenytoin, phenobarbital, diazepam, clonazepam, vigabatrin, or valproic acid. Histologic examination of the brains revealed that these drugs cause widespread and dose-dependent apoptotic neurodegeneration in the developing rat brain during the brain growth spurt period. Apoptotic neurodegeneration was triggered at plasma drug levels relevant for seizure control in humans. Antiepileptic drugs lead to reduced expression of neurotrophins and decreased concentrations of the active forms of ERK1/2, RAF, and AKT. P-Estradiol, which stimulates pathways that are activated by neurotrophins, ameliorated AEDs-induced apoptotic neurodegeneration. Our findings present one possible mechanism to explain cognitive impairment and reduced brain mass associated with pre- or postnatal exposure of humans to antiepileptic therapy.
引用
收藏
页码:103 / 114
页数:12
相关论文
共 34 条
[1]   Neuroprotective activities of estrogen: An update [J].
Behl, C ;
Manthey, D .
JOURNAL OF NEUROCYTOLOGY, 2000, 29 (5-6) :351-358
[2]   Drug therapy - Antiepileptic drugs [J].
Brodie, MJ ;
Dichter, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :168-175
[3]   PRENATAL PREDICTION OF RISK OF THE FETAL HYDANTOIN SYNDROME [J].
BUEHLER, BA ;
DELIMONT, D ;
VANWAES, M ;
FINNELL, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (22) :1567-1572
[4]   Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin [J].
Dalby, NO ;
Nielsen, EB .
EPILEPSY RESEARCH, 1997, 28 (01) :63-72
[5]   IMPROVED CUPRIC-SILVER METHOD FOR IMPREGNATION OF AXONAL AND TERMINAL DEGENERATION [J].
DEOLMOS, JS ;
INGRAM, WR .
BRAIN RESEARCH, 1971, 33 (02) :523-&
[6]   Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems [J].
Dessens, AB ;
Cohen-Kettenis, PT ;
Mellenbergh, GJ ;
Koppe, JG ;
van de Poll, NE ;
Boer, K .
ACTA PAEDIATRICA, 2000, 89 (05) :533-541
[7]   COMPARATIVE ASPECTS OF THE BRAIN GROWTH SPURT [J].
DOBBING, J ;
SANDS, J .
EARLY HUMAN DEVELOPMENT, 1979, 3 (01) :79-83
[8]   PHENOBARBITAL FOR FEBRILE SEIZURES - EFFECTS ON INTELLIGENCE AND ON SEIZURE RECURRENCE [J].
FARWELL, JR ;
LEE, YJ ;
HIRTZ, DG ;
SULZBACHER, SI ;
ELLENBERG, JH ;
NELSON, KB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :364-369
[9]   Vigabatrin: A novel therapy for seizure disorders [J].
Gidal, BE ;
Privitera, MD ;
Sheth, RD ;
Gilman, JT .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) :1277-1286
[10]   SOME NEW, SIMPLE AND EFFICIENT STEREOLOGICAL METHODS AND THEIR USE IN PATHOLOGICAL RESEARCH AND DIAGNOSIS - REVIEW ARTICLE [J].
GUNDERSEN, HJG ;
BENDTSEN, TF ;
KORBO, L ;
MARCUSSEN, N ;
MOLLER, A ;
NIELSEN, K ;
NYENGAARD, JR ;
PAKKENBERG, B ;
SORENSEN, FB ;
VESTERBY, A ;
WEST, MJ .
APMIS, 1988, 96 (05) :379-394